As oncology research centers scale eSource adoption, the field is shifting toward a fully digital, clinical trial ecosystem.

Since the Orphan Drug Act went into effect in 1983, more than 600 drugs have been approved for rare diseases, according to ...

In this video interview, Thierry Escudier, portfolio lead, Pistoia Alliance, talks the current landscape of sustainability in clinical trials and how stakeholders are beginning to pay more attention ...

Many clinical researchers lament the rise of misinformation and yearn for the orderly days of fewer, more authoritative ...

Why investing in truly effective training from the outset can pay off exponentially for clinical teams—and serve as a ...

In this video interview, Thierry Escudier, portfolio lead, Pistoia Alliance, discusses the alliance’s latest step in ...

Research collaboration between Tufts and the Society for Clinical Research Sites explores the prevalence of this belief in ...

Exploring the different stages in the development of a digital measure and the activities and steps key to achieving meaningful impact for patients.

In this video interview, Thierry Escudier, portfolio lead, Pistoia Alliance, highlights where regulatory agencies currently stand on sustainability in clinical trials and how pharma companies are ...

The Phase III API-CAT trial found that extended anticoagulant therapy with reduced-dose Eliquis (apixaban) was noninferior to ...

In this video interview, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA), highlights how recent ...

In this video interview, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA), discusses numerous themes that clin ops can focus on to keep its trials running efficiently and ...